Travere Therapeutics
TVTX
#3177
Rank
S$6.21 B
Marketcap
S$64.75
Share price
-1.68%
Change (1 day)
38.25%
Change (1 year)

EPS for Travere Therapeutics (TVTX)

EPS in 2026 (TTM): S-$1.66

According to Travere Therapeutics's latest financial reports the company's current EPS (TTM) is S-$1.66. In 2025 the company made an earnings per share (EPS) of S-$0.37 an increase over its 2024 EPS that were of S-$5.28.

EPS history for Travere Therapeutics from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$1.66343.3%
2025S-$0.37-92.93%
2024S-$5.28154.66%
2023S-$2.08-63.16%
2022S-$5.6344.22%
2021S-$3.91-10.09%
2020S-$4.34
2018S-$3.2764.94%
2017S-$1.98
2015S$4.65

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
S-$0.24-85.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
S-$1.22-26.36%๐Ÿ‡บ๐Ÿ‡ธ USA